Nemaura Successfully Completes Clinical Studies for SugarBEAT® FDA De-Novo 510(k) Submission

Nemaura Medical Inc., a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, today reported that it has successfully completed the c https://globenewswire.com/news-release/2018/12/04/1661588/0/en/Nemaura-Successfully-Completes-Clinical-Studies-for-SugarBEAT-FDA-De-Novo-510-k-Submission.html